Houston, TX – April 17, 2025 - The University of Glasgow’s Living Laboratory for Precision Medicine and myDNA, a leader in precision health, have announced a new partnership to generate evidence supporting the adoption of pharmacogenomics (PGx) in healthcare. The collaboration will focus on exploring the potential of PGx to transform healthcare delivery, aiming to [...]

Dr. Lior Rauchberger, CEO of leading Australian genomics company, myDNA, announced a merger with the U.S., Houston-based consumer DNA test company, FamilyTreeDNA, and its parent company, Gene by Gene. Dr. Rauchberger will step into the role of CEO of the merged companies, effective immediately. Gene by Gene co-founders Bennett Greenspan and Max Blankfeld will join the Board of Directors. FamilyTreeDNA, [...]

The vision to offer pharmacogenomic tests to the Australian public came from myDNA founder Associate Professor Les Sheffield. A pioneer in his field, Les became the first Australian to qualify as a clinical geneticist in 1976. At the Royal Women’s and Children’s Hospitals he specialised in genetic tests and oversaw the introduction of Down's syndrome [...]

Some things are better kept secret: your pin number, passwords and most definitely your DNA. After all, what’s more personal than your genetic code? It’s what makes you unique. You might have heard about the American DNA testing company, 23andMe, that has made a USD $300million deal with a pharmaceutical company, giving it exclusive access [...]